⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of IBSA Group and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
IBSA Group
↗Lugano, Switzerland
IBSA Group is a Swiss multinational pharmaceutical company founded in 1945 and headquartered in Lugano, Switzerland. The company is a privately-owned leader in reproductive medicine and hyaluronic acid-based products, operating across 10 therapeutic areas including endocrinology, pain management, and dermatology.
With a global presence spanning over 90 countries and 20 subsidiaries, IBSA focuses on innovation in drug delivery systems, such as orodispersible films and advanced injectable formulations. The company emphasizes a patient-centric philosophy built on four pillars: Person, Innovation, Quality, and Responsibility.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Reproductive medicine, Endocrinology, Pain management
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$1B+
Founded:1945
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Hyaluronic acid-based products, Injectables, Orodispersible films
Trial Phases:-
CORPORATE STRUCTURE
Subsidiaries:IBSA USA
COMPETITION
Position:Leader
LEADERSHIP
Key Executives:
Nicholas Hart - CEO (IBSA USA)
Luca Grassi - Group CFO
Carolyn Kong - Chief Business & Medical Affairs Officer (IBSA USA)
LINKS
Website:ibsagroup.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with IBSA Group. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.